EHCS — European Healthcare Acquisition & Growth BV Income Statement
0.000.00%
Last trade - 00:00- €71.94m
- €70.98m
Annual income statement for European Healthcare Acquisition & Growth BV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 6 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Cost of Revenue | |||
| Selling / General / Administrative Expenses | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 1.72 | 16.2 | 5.93 |
| Operating Profit | -1.72 | -16.2 | -5.93 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | -2.53 | -30.1 | 26.7 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -2.53 | -30.1 | 26.5 |
| Net Income Before Extraordinary Items | |||
| Net Income | -2.53 | -30.1 | 26.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -2.53 | -30.1 | 26.5 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -1.51 | -4.51 | 3.97 |
| Dividends per Share |